Epidemiology of HPV Related Malignancies

Overview

Journal Semin Radiat Oncol

Specialties Oncology
Radiology

Date 2021 Aug 30

PMID 34455984

Citations 24

Authors

Nicholas Scott-Wittenborn

Carole Fakhry

Affiliations

Soon will be listed here.

Abstract

Human papillomavirus is the most common sexually transmitted infection in the world and had been linked to both anogenital and oropharyngeal cancers. It causes nearly 100% of cervical cancers and an increasing portion of oropharyngeal cancers. The geographical burden of cervical HPV infection and associated cancers is not uniform and is mainly found in low middle income countries in South America, Africa, and Asia. However, HPV-positive oropharyngeal cancer is rapidly becoming more prevalent in high middle income countries. With the development of vaccines which prevent HPV infection, the World Health Organization has designated the extirpation of HPV and its associated cancers a priority. Countries that have implemented adequate vaccine programs have shown a decrease in HPV prevalence. Understanding the epidemiology of HPV and its associated cancers is fundamental in improving vaccine programs and other health programs.

Citing Articles

Understanding and treating HPV-associated oropharyngeal carcinoma: insights from a MedNewsWeek Keynote lecture by Dr Theodoros N. Teknos and literature review.

Cortiana V, Nadar S, Gambill J, Mahendru D, Theyver A, Coloma H Ther Adv Med Oncol. 2025; 17:17588359251322290.

PMID: 40008193 PMC: 11851760. DOI: 10.1177/17588359251322290.

HTLV-1 Infection and Cervicovaginal Susceptibility to High-Risk HPV: Findings from Women Living with HTLV-1 in Salvador, Brazil.

de Aquino Firmino A, Filho P, Siqueira J, Gois L, Costa G, Martins A Viruses. 2025; 17(2).

PMID: 40006895 PMC: 11860536. DOI: 10.3390/v17020140.

An Assessment of Young Adults' Awareness and Knowledge Related to the Human Papillomavirus (HPV), Oropharyngeal Cancer, and the HPV Vaccine.

Davis E, Doyle P Cancers (Basel). 2025; 17(3).

PMID: 39941716 PMC: 11816247. DOI: 10.3390/cancers17030344.

Knowledge and attitudes about human papillomavirus infection and prevention methods among medical science students in Novi Sad, Serbia: a cross-sectional study.

Denda N, Maletin N, Raskovic A, Prodanovic D, Golusin Z, Vuckovic B BMC Public Health. 2025; 25(1):332.

PMID: 39871227 PMC: 11770917. DOI: 10.1186/s12889-025-21593-y.

How can HPV E6 manipulate host cell differentiation process to maintain the reservoir of infection.

Chen Y, Egawa N, Zheng K, Doorbar J Tumour Virus Res. 2025; 19:200313.

PMID: 39832674 PMC: 11847044. DOI: 10.1016/j.tvr.2025.200313.

References

Melchers L, Mastik M, Samaniego Cameron B, van Dijk B, de Bock G, van der Laan B . Detection of HPV-associated oropharyngeal tumours in a 16-year cohort: more than meets the eye. Br J Cancer. 2015; 112(8):1349-57. PMC: 4402463. DOI: 10.1038/bjc.2015.99. View

Srivastava S, Gupta S, Roy J . High prevalence of oncogenic HPV-16 in cervical smears of asymptomatic women of eastern Uttar Pradesh, India: a population-based study. J Biosci. 2012; 37(1):63-72. DOI: 10.1007/s12038-012-9181-y. View

Kahn J, Brown D, Ding L, Widdice L, Shew M, Glynn S . Vaccine-type human papillomavirus and evidence of herd protection after vaccine introduction. Pediatrics. 2012; 130(2):e249-56. PMC: 3408690. DOI: 10.1542/peds.2011-3587. View

Rosen B, Walter L, Gilman R, Cabrerra L, Gravitt P, Marks M . Prevalence and correlates of oral human papillomavirus infection among healthy males and females in Lima, Peru. Sex Transm Infect. 2015; 92(2):149-54. PMC: 5463743. DOI: 10.1136/sextrans-2014-051942. View

de Martel C, Georges D, Bray F, Ferlay J, Clifford G . Global burden of cancer attributable to infections in 2018: a worldwide incidence analysis. Lancet Glob Health. 2019; 8(2):e180-e190. DOI: 10.1016/S2214-109X(19)30488-7. View

Seoud M . Burden of human papillomavirus-related cervical disease in the extended middle East and north Africa-a comprehensive literature review. J Low Genit Tract Dis. 2012; 16(2):106-20. DOI: 10.1097/LGT.0b013e31823a0108. View

Kreimer A, Clifford G, Boyle P, Franceschi S . Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005; 14(2):467-75. DOI: 10.1158/1055-9965.EPI-04-0551. View

Hang D, Liu F, Liu M, He Z, Sun M, Liu Y . Oral human papillomavirus infection and its risk factors among 5,410 healthy adults in China, 2009-2011. Cancer Epidemiol Biomarkers Prev. 2014; 23(10):2101-10. DOI: 10.1158/1055-9965.EPI-14-0084. View

De Cicco R, de Melo Menezes R, Nicolau U, Pinto C, Villa L, Kowalski L . Impact of human papillomavirus status on survival and recurrence in a geographic region with a low prevalence of HPV-related cancer: A retrospective cohort study. Head Neck. 2019; 42(1):93-102. DOI: 10.1002/hed.25985. View

10.

Chen F, Yan L, Liu F, Huang J, Liu F, Wu J . Oral human papillomavirus infection, sexual behaviors and risk of oral squamous cell carcinoma in southeast of China: A case-control study. J Clin Virol. 2016; 85:7-12. DOI: 10.1016/j.jcv.2016.10.011. View

11.

Paquette C, Evans M, Meer S, Rajendran V, Adamson C, Cooper K . Evidence that alpha-9 human papillomavirus infections are a major etiologic factor for oropharyngeal carcinoma in black South Africans. Head Neck Pathol. 2013; 7(4):361-72. PMC: 3824804. DOI: 10.1007/s12105-013-0453-0. View

12.

Argirion I, Zarins K, Defever K, Suwanrungruang K, Chang J, Pongnikorn D . Temporal Changes in Head and Neck Cancer Incidence in Thailand Suggest Changing Oropharyngeal Epidemiology in the Region. J Glob Oncol. 2019; 5:1-11. PMC: 6449079. DOI: 10.1200/JGO.18.00219. View

13.

Stelzle D, Tanaka L, Lee K, Ibrahim Khalil A, Baussano I, Shah A . Estimates of the global burden of cervical cancer associated with HIV. Lancet Glob Health. 2020; 9(2):e161-e169. PMC: 7815633. DOI: 10.1016/S2214-109X(20)30459-9. View

14.

Wabinga H, Nambooze S, Amulen P, Okello C, Mbus L, Parkin D . Trends in the incidence of cancer in Kampala, Uganda 1991-2010. Int J Cancer. 2014; 135(2):432-9. DOI: 10.1002/ijc.28661. View

15.

Rettig E, Zaidi M, Faraji F, Eisele D, El Asmar M, Fung N . Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Cancer Database. Oral Oncol. 2018; 83:147-153. PMC: 6500732. DOI: 10.1016/j.oraloncology.2018.06.013. View

16.

Ernster J, Sciotto C, OBrien M, Finch J, Robinson L, Willson T . Rising incidence of oropharyngeal cancer and the role of oncogenic human papilloma virus. Laryngoscope. 2007; 117(12):2115-28. DOI: 10.1097/MLG.0b013e31813e5fbb. View

17.

Ribeiro K, Levi J, Pawlita M, Koifman S, Matos E, Eluf-Neto J . Low human papillomavirus prevalence in head and neck cancer: results from two large case-control studies in high-incidence regions. Int J Epidemiol. 2011; 40(2):489-502. DOI: 10.1093/ije/dyq249. View

18.

Garland S, Kjaer S, Munoz N, Block S, Brown D, DiNubile M . Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience. Clin Infect Dis. 2016; 63(4):519-27. PMC: 4967609. DOI: 10.1093/cid/ciw354. View

19.

Quintero K, Giraldo G, Uribe M, Baena A, Lopez C, Alvarez E . Human papillomavirus types in cases of squamous cell carcinoma of head and neck in Colombia. Braz J Otorhinolaryngol. 2013; 79(3):375-81. PMC: 9478765. DOI: 10.5935/1808-8694.20130065. View

20.

Faraji F, Rettig E, Tsai H, El Asmar M, Fung N, Eisele D . The prevalence of human papillomavirus in oropharyngeal cancer is increasing regardless of sex or race, and the influence of sex and race on survival is modified by human papillomavirus tumor status. Cancer. 2018; 125(5):761-769. DOI: 10.1002/cncr.31841. View